BackgroundCheck.run
Search For

Neil Louis Goldstein, 5237 Richmond Ln, Hartford, CT 06117

Known as:
Neil L Goldstein Neil L Goldberg
Related to:
Adam J Goldstein 46 Lily Goldstein

Neil Goldstein Phones & Addresses

225 70Th St, New York, NY 10021    212-5709338   

225 E 70Th St APT 7D, New York, NY 10021   

Hartford, CT   

Brooklyn, NY   

College Park, MD   

Work

Company: Robinson Brog Leinwand Greene Genovese & Gluck P.C. Address: 1345 Avenue Of The Americas, New York, NY 10105 Specialities: Tax - 34% • Real Estate - 33% • Corporate / Incorporation - 33%

Education

Degree: B.B.A. School / High School: City College

Ranks

Licence: New York - Currently registered Date: 1968
Get Report
Control this profile

Mentions for Neil Louis Goldstein

Career records & work history

Lawyers & Attorneys

Neil Goldstein Photo 1

Neil Shelby Goldstein, New York NY - Lawyer

Address:
Robinson Brog Leinwand Greene Genovese & Gluck P.C.
1345 Avenue Of The Americas, New York, NY 10105
212-6036300 (Office), 212-6030486 (Fax)
Licenses:
New York - Currently registered 1968
Education:
City CollegeDegree B.B.A.
Specialties:
Tax - 34%
Real Estate - 33%
Corporate / Incorporation - 33%
Associations:
Association of the Bar of the City of New York - Member

License Records

Neil Brian Goldstein

Licenses:
License #: 1141 - Active
Issued Date: Jan 28, 1993
Expiration Date: Jun 30, 2017
Organization:
Firm Not Published

Neil Kenneth Goldstein Md

Licenses:
License #: 22335 - Expired
Category: Medicine
Issued Date: Nov 20, 2002
Effective Date: Oct 3, 2014
Expiration Date: Oct 1, 2014
Type: Physician

Publications & IP owners

Us Patents

Monoclonal Antibodies Specific To Vegf Receptors And Uses Thereof

US Patent:
6365157, Apr 2, 2002
Filed:
Sep 22, 1999
Appl. No.:
09/401163
Inventors:
Patricia Rockwell - West Readding CT
Neil I. Goldstein - Maplewood NJ
Assignee:
ImClone Systems, Inc. - New York NY
International Classification:
A01N 3718
US Classification:
4241561, 4241381, 4241431, 514 2, 435330, 435334
Abstract:
Monoclonal antibodies that specifically bind to an extracellular domain of a flt-1 receptor and neutralize activation of the receptor are provided. In vitro and in vivo methods of using these antibodies are also provided.

Methods For Indentifying Anti-Cancer Agents

US Patent:
6413717, Jul 2, 2002
Filed:
Mar 18, 1998
Appl. No.:
09/040981
Inventors:
Yilong Sun - Fort Lee NJ
Paul B. Fisher - Scarsdale NY
Neil I. Goldstein - Maplewood NJ
Assignee:
Corixa Corporation - Seattle WA
International Classification:
C12Q 168
US Classification:
435 6, 435 912
Abstract:
Methods are provided for identifying agents that modulate the expression of genes, such as genes encoding tumor suppressor or tumor-promoting proteins. The methods generally comprise screening candidate agents for the ability to enhance expression of a tumor suppressor gene, such as mda-7, or for the ability to inhibit expression of a tumor-promoting gene within a cell. Modulating agents may be used, for example, within anti-cancer therapies.

Humanized Anti-Egf Receptor Monoclonal Antibody

US Patent:
7060808, Jun 13, 2006
Filed:
Jun 7, 1996
Appl. No.:
08/973065
Inventors:
Neil I. Goldstein - Maplewood NJ, US
Nicholas A. Giorgio - New York NY, US
Steven Tarran Jones - Radlett, GB
Jose William Saldanha - Enfield, GB
Assignee:
ImClone Systems Incorporated - New York NY
International Classification:
C07H 21/04
US Classification:
536 231, 536 2353, 5303873, 53038885, 435 691, 435 696, 435325, 4352523
Abstract:
A nucleic acid is provided which encodes a humanized antibody or fragment thereof, which encodes a protein which binds to human EGF-receptor. Monoclonal antibody 225 is the complementary determining region (CDR) donor.

Methods For Identifying Oncogenes And Tumor-Associated Proteins

US Patent:
2003021, Nov 27, 2003
Filed:
May 6, 2002
Appl. No.:
10/139732
Inventors:
Paul Fisher - Scarsdale NY, US
Neil Goldstein - Maplewood NJ, US
International Classification:
G01N033/53
C07H021/04
C12P021/02
C12N005/06
C07K016/30
US Classification:
435/007100, 435/069100, 435/326000, 435/320100, 530/388800, 536/023530
Abstract:
This invention provides a method for preparing antibodies directed against a protein associated with a cancer, comprising the steps of: (a) transfecting non-tumorigenic cells with a cDNA library comprising cDNA molecules derived from mRNA of cancer cells; (b) masking the transfected cells with antibodies raised against non-tumorigenic cells transfected with a cDNA library derived from normal cells; and (c) generating antibodies against the masked cells, and thereby generating antibodies directed against a protein associated with a cancer.

Antibody And Antibody Fragments For Inhibiting The Growth Of Tumors

US Patent:
2003022, Dec 4, 2003
Filed:
Feb 25, 2003
Appl. No.:
10/374600
Inventors:
Neil Goldstein - Maplewood NJ, US
Nicholas Giorgio - New York NY, US
Steven Jones - Radlett, GB
Jose Saldanha - Enfield, GB
International Classification:
A61K039/395
C07H021/04
C07K016/30
C07K016/46
US Classification:
424/178100, 530/388800, 530/391100, 536/023530
Abstract:
Chimerized and humanized versions of anti EGF receptor antibody 225 and fragments thereof for treatment of tumors.

Antibody And Antibody Fragments For Inhibiting The Growth Of Tumors

US Patent:
2004000, Jan 8, 2004
Filed:
Feb 25, 2003
Appl. No.:
10/374531
Inventors:
Neil Goldstein - Maplewood NJ, US
Nicholas Giorgio - New York NY, US
Steven Jones - Radlett, GB
Jose Saldanha - Enfield, GB
International Classification:
C07K016/30
US Classification:
530/387100, 530/391100
Abstract:
Chimerized and humanized versions of anti EGF receptor antibody 225 and fragments thereof for treatment of tumors.

Antibody And Antibody Fragments For Inhibiting The Growth Of Tumors

US Patent:
2007011, May 24, 2007
Filed:
Jun 13, 2006
Appl. No.:
11/453345
Inventors:
Neil Goldstein - Maplewood NJ, US
Nicholas Giorgio - New York NY, US
Steven Jones - Radlett, GB
Jose Saldanha - Enfield, GB
International Classification:
A61K 39/395
C07H 21/04
C12P 21/06
C12N 5/06
C07K 16/30
C07K 16/46
A61K 33/24
US Classification:
424155100, 424178100, 424649000, 530388800, 530391100, 536023530, 435069100, 435338000, 435320100
Abstract:
Chimerized and humanized versions of anti EGF receptor antibody 225 and fragments thereof for treatment of tumors.

Antibody And Antibody Fragments For Inhibiting The Growth Of Tumors

US Patent:
2009009, Apr 16, 2009
Filed:
Jul 9, 2008
Appl. No.:
12/170080
Inventors:
Neil I. Goldstein - Maplewood NJ, US
Nicholas A. Giorgio - New York NY, US
Steven Tarran Jones - Radlett, GB
Jose William Saldanha - Enfield, GB
Assignee:
ImClone Systems Incorporated - New York NY
International Classification:
C07K 16/18
US Classification:
5303871, 5303917
Abstract:
Chimerized and humanized versions of anti EGF receptor antibody 225 and fragments thereof for treatment of tumors.

Isbn (Books And Publications)

Developing Object-Oriented Software For The Macintosh: Analysis, Design And Programming

Author:
Neil Goldstein
ISBN #:
0201570653

Usmle Step 1: United States Medical Licensing Examination

Author:
Neil Goldstein
ISBN #:
0878910743

Slutdikat: Kronotorpare I Byn Naisheden, Norrbotten

Author:
Neil Goldstein
ISBN #:
9138043661

Malarslott

Author:
Neil Goldstein
ISBN #:
9171560998

Possible Relatives

David Goldstein  Dawn E Goldstein  Deanna J Goldstein  Dale A Goldstein  Debora S Goldstein  Deborah V Goldstein  Danelle M Goldstein  Neil W Johnson  Neil H Stanfield  Neil T White 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.